Biotech Values

[DewDiligence]

JNJ is also a pretty good biotech these days, albeit primarily via acquisitions. But we know why that is not on your list.

Not sure what you are driving at.

JNJ’s woes with OTC product recalls and flawed orthopedic implants are well known and are reflected in the stock price, IMO. The main reason I don’t own JNJ is simply that I consider other biotech/healthcare stocks more attractive.